“This is going to be bigger than bingo,” James Billie told CNN over the summer. A former chief of the Seminole, whose company MCW gives financing and legal counsel to American Indian tribes to help them grow and sell marijuana on their land, Billie could barely contain his excitement.
Tag Archives: Profit
Well, we have news for Canadian marijuana stock investors: There’s a new threat on the horizon, at least for our neighbors to the north.
On June 27, Cara Therapeutics (NASDAQ:CARA), a clinical-stage biotech company with a focus on treating chronic pain and pruritus, surged to an all-time intraday high of $28.50 a share. Cara was just $73 million away from joining the $1 billon market cap ranks.
Canadian marijuana players have been rushing to invest and take strategic positions in the new Germany medical cannabis market since late 2016, and this trend is set to continue going forward.
Mexican medical marijuana businesses and their investors will have a long time to wait before seeing profits from the newly legalized industry.
Though there are a number of direct players in the industry, some of the most surprising growth can be seen in emerging industry players. One such name is Scotts Miracle-Gro.
On July 1, 2017, Nevada will legalize the use and sale of recreational marijuana, which could be a catalyst for long-term gains for three cannabis stocks.
The industry and the Canopy Growth Corp. were going to be the next big thing for investors, but things have cooled down gradually over the past few months.
Here is a novel concept could increase the safety of cannabis deliveries and be a boon for marijuana stocks: drone deliveries. Not only will drone deliveries increase safety, but they will also make delivery faster and more convenient.
It is apparent that Aphria Inc. will be one of the major winners among marijuana companies. The timing of when to buy shares might be a bit tougher, though.
Today we’re going to share seven essential tips that will help you save both time and money and invest in cannabis stocks as profitably as possible.
Here are 4 top stocks in the growing medical marijuana industry that have a tremendous amount of potential for investors.
U.S. real estate values are blazing, at least that is in the parts of the country where the sale of marijuana is now legal.
Many companies are set to prosper under this new segment of the economy, and licensed producer of marijuana, Aphria Inc, is set flourish under such conditions.
While the potential market is huge, there’s just one problem. All of Canada’s marijuana stocks are so expensive that no valuation-based investor will touch them. Fortunately, there are ways investors can have their cake and eat it too. All you need to do is identify industries that will get a nice bump from legal pot.
In this World of Cannabis Interview, watch Caroline Cahill, Managing Editor of MJINews.com and Marijuana Industry News magazine, interview Kevin Sutherland, CEO of Canna Mergers.
Aphria Inc. is the newest weed company to graduate to the TSX. The stock has been faring better than its peers, Canopy Growth Corp. and Aurora Cannabis Inc. over the past few months.
American Vice: Black Market Marijuana follows four outlaws who run successful businesses growing, selling, and distributing illegal marijuana.
Marijuana has quickly become the next “can’t miss” investing idea for investors across North America. Despite this huge potential market, people are reluctant to put any of their cash into this market
There are a number of big institutions, including mutual funds, pension funds, and investment banks, that use the TSX Composite and its sub-indices as performance benchmarks for their portfolios. The addition of Canopy to the index will introduce some new dimensions to the index’s performance.
Buying, selling or investing in any business requires proper due diligence. In the cannabis industry – you need to take extra steps. Hear Kevin Sutherland, CEO of Canna Mergers, and Paul Shively, a compliance expert, discuss the diligence you need to perform as you invest in the legal cannabis industry.
There’s been something in the air on the ASX recently and it’s inducing some strange behaviour in traders betting on higher and higher share prices in some emerging companies.
The investing community demands regular performance updates in the form of financial reports. While the need to impress investors is creating pressure for the infant marijuana industry, are the companies fairly reporting performance?
An industry previously only regulated by law enforcement leaves tremendous uncertainty for those looking to get into the industry from an investment perspective. Organizations like MJIC are stepping up to provide regulatory support and protection for marijuana operators.
In Oregon, Washington state and Colorado, marijuana tax revenues totaled at least $335 million in either the last calendar year or the last fiscal year.
Investors in cannabis companies had an eventful 2016 with the approval of recreational marijuana usage in the states of California, Massachusetts, Maine, and Nevada providing a boost to all sorts of marijuana stocks. Of particular note, shares of Corbus Pharmaceuticals (NASDAQ: CRBP) posted a whopping 600% gain in 2016 following positive phase 2 data.
Canopy Growth Corp. has garnered the most attention and established itself as the market leader; however, there is another company in the Canadian marijuana industry that could emerge as a potential winner.
Since seeing all the buzz and craze these companies are causing in the marketplace, we’ve been hot on the trail of companies tied to the cannabis sector. The budding marijuana industry has spawned several high flying stocks lately, like Mentor Capital Inc.
Marijuana stocks are riding high as the stock index is up for the eighth consecutive week.
Investors are incredibly excited about Canopy Growth Corporation. But we’re now looking at a situation where the stock has increased quite aggressively thanks mostly to the belief that the future is bright. And there are still many investors sitting on the sidelines wondering if they should consider this company.
Marty Higgins, CEO of San Francisco-based Harvest, explains how the company is redefining the retail experience for the modern dispensary customer.
Canadian weed? It’s supposed to be pretty good.But Arizona medical marijuana? Super profitable. Ask the people from a Toronto firm who recently announced the “acquisition” — with caveats and disclaimers — of two Mesa dispensaries.
Investing in cannabis stocks is being called the “gold rush” of the 21st century. That’s because legal marijuana sales in North America climbed to $6.7 billion in 2016.
The market for marijuana is exploding as Americans overwhelmingly embrace legalization. Analysts are projecting tens of billions of dollars in future marijuana sales, making this an intriguing market for investors.
The recent failure of Issue 3 to legalize marijuana in Ohio may say as much about state politics and corporate greed as it does about the progress of cannabis legalization across the country.
Ownership in the Medicine Man Denver stores—there are two now, one near the airport in Denver and one in Aurora—is not actually what is being pitched to investors in the S-1 from Medicine Man Technologies. The business of Medicine Man Technologies is actually consulting, but its model and outlook are inexorably tied to the highly successful cultivator and retailer you may have seen on MSNBC’s “Pot Barons” TV series.
On a drug farm miles from anywhere in the central Andean mountains of Colombia, workers are digging up marijuana bushes and replacing them with avocados.
Cannabis stocks struggled on this Friday trading session. Volumes were low, profit taking in recent high flyers, and poor trading behavior to cap out the week.
Investing “in the plant” remains a road that can only be traveled by a select few in the United States. But in Canada, it is a whole different story.
Marijuana legalization will always be a cause to some people, while for others it will never amount to more than a financial opportunity. But what about the middle ground?
Mark Kleiman’s recent piece in Slate argues against the commercialization of legal marijuana that would take it in the direction of Big Alcohol.
The day opened with concerns over Japan’s recession and a slump in small-caps led to fluctuation of stocks on the news. However, the S&P 500 worked its way to a marginal win to close at 2,041.
Legal is good. Legal and prosperous is better, as far as investors are concerned. Now that five jurisdictions have opened the door to a recreational marijuana industry, it is time to re-examine the legal structure it takes to support a healthy business climate.
DENVER, Oct. 29, 2014 /PRNewswire/ — ChineseInvestors.COM (OTCQB ‘CIIX’) was pleased with its first quarter results in generating a comprehensive profit of $147,501 on revenues of $644,787.
The financials behind the marijuana industry is undoubtedly lucrative, but just how lucrative exactly?